1. Contract R&D
2. Microbiology
2.1. Medical
2.1.1. Sterility Testiing
2.1.1.1. Drugs
2.1.2. Efficacy Testing
2.1.2.1. Antibiotics
2.1.2.2. Anti Fungal
2.1.3. Anti Microbial Activity Evaluation
2.2. Agro
2.2.1. Toxicity Testing
2.3. Industrial
2.3.1. Food
2.3.1.1. QC
3. *in-vitro *
3.1. Plant Tissue Culture
3.2. Animal Cell Culture
3.2.1. Stem cells
3.2.2. Cell lines
4. Microscopy
5. Repository
5.1. Bio Repository
5.2. Microbial Type Cell Culture Facility
6. Biochemical
6.1. Compound Isolation
6.2. Chromatography
6.3. Blood Plasma
7. *in-vivo *
8. Olio Synthesize
8.1. Custom DNA Synthesis
8.1.1. Primers
8.1.2. Short Oligos Synthesis
8.1.3. cDNA Synthesis
8.1.4. Gene Synthesis
9. Molecular Diagnostics
9.1. Human/Animal
9.2. Plant
10. Immuno Diagnostics
11. Omics
11.1. Proteomics
11.1.1. Recombinant Protein Synthesis
11.1.2. Synthetic Peptide Synthesis
11.1.3. Cosmeceuticals
11.1.4. Protein Analysis
11.1.5. Immuno-proteomic
11.1.5.1. Monoclonal Antibody
11.1.5.2. Cell-line Development
11.1.5.3. Stem Cells
11.1.5.4. Allergenocity
11.1.5.5. B cell and T cell epitopes
11.2. Genomics
11.2.1. Whole Genome Sequencing
11.2.2. Whole Exome Sequencing
11.2.3. Targeted Genome Sequencing
11.2.3.1. Cancer
11.2.3.1.1. Breast BRCA1and BRCA2
11.2.3.1.2. Lung,Colon,Bladder,Prostate, Pancreatic, Leukemia
11.2.3.2. HLA Typing
11.2.3.3. Forensics
11.2.3.4. Immuno-defficincy
11.2.3.5. Fertility
11.2.4. Metagenomic Sequencing
11.2.5. Epigenomics
11.2.5.1. Chromosome Accessibility
11.2.5.1.1. ChiP-Seq
11.2.5.1.2. ATAC-Seq
11.2.5.2. DNA Methylation
11.2.5.2.1. MeDIP-Seq
11.2.5.2.2. Bisulfiite-Seq
11.3. Transcriptomics
11.3.1. Total RNA-seq
11.3.2. mRNA Sequencing
11.3.3. Target RNA-Seq
11.3.4. Metatranscriptomics
11.3.5. ncRNA-Seq